Cadmus Animal Health Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$500K
- Investors
-
2
Cadmus Animal Health General Information
Description
Developer of an immunotherapeutic drug designed to treat chronic periodontal disease caused by the Porphyromonas bacterium in companion animals. The company offers a targeted treatment approach, enabling veterinarians to address the underlying cause of periodontal disease, improving the oral health of pets.
Contact Information
Website
www.cadmusah.comCorporate Office
- Care of Minter Ellison Rudd Watts, Level 22
- Pwc Tower, 15 Customs Street West
- Auckland, 1010
- New Zealand
Corporate Office
- Care of Minter Ellison Rudd Watts, Level 22
- Pwc Tower, 15 Customs Street West
- Auckland, 1010
- New Zealand
Cadmus Animal Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 06-Aug-2025 | $500K | Completed | Startup | ||
| 1. Early Stage VC | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cadmus Animal Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cadmus Animal Health Patents
Cadmus Animal Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024298172-A1 | Chimeric protein vaccine | Pending | 26-Jul-2023 | ||
| EP-4750489-A1 | Chimeric protein vaccine | Pending | 26-Jul-2023 | ||
| JP-2026530733-A | Chimeric protein vaccine | Pending | 26-Jul-2023 | ||
| AU-2024301594-A1 | Rna vaccines for use in animal health | Pending | 26-Jul-2023 | ||
| EP-4750491-A1 | Rna vaccines for use in animal health | Pending | 26-Jul-2023 | C07K14/195 |
Cadmus Animal Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cadmus Animal Health Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Booster Innovation Fund | Venture Capital | Minority | ||
| Brandon Capital | Venture Capital | Minority |
Cadmus Animal Health FAQs
-
When was Cadmus Animal Health founded?
Cadmus Animal Health was founded in 2021.
-
Where is Cadmus Animal Health headquartered?
Cadmus Animal Health is headquartered in Auckland, New Zealand.
-
What is the size of Cadmus Animal Health?
Cadmus Animal Health has 4 total employees.
-
What industry is Cadmus Animal Health in?
Cadmus Animal Health’s primary industry is Other Services (B2C Non-Financial).
-
Is Cadmus Animal Health a private or public company?
Cadmus Animal Health is a Private company.
-
What is Cadmus Animal Health’s current revenue?
The current revenue for Cadmus Animal Health is .
-
How much funding has Cadmus Animal Health raised over time?
Cadmus Animal Health has raised $500K.
-
Who are Cadmus Animal Health’s investors?
Booster Innovation Fund and Brandon Capital have invested in Cadmus Animal Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
